|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
3
|
Verslype C, Van Cutsem E, Dicato M, et al:
The management of hepatocellular carcinoma. Current expert opinion
and recommendations derived from the 10th World Congress on
Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol. 20(Suppl 7):
vii1–vii6. 2009. View Article : Google Scholar
|
|
4
|
Sia D and Villanueva A: Signaling pathways
in hepatocellular carcinoma. Oncology. 81(Suppl 1): S18–S23. 2011.
View Article : Google Scholar
|
|
5
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luo J, Manning BD and Cantley LC:
Targeting the PI3K-Akt pathway in human cancer: rationale and
promise. Cancer Cell. 4:257–262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sabatini DM: mTOR and cancer: insights
into a complex relationship. Nat Rev Cancer. 6:729–734. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kong D and Yamori T: Advances in
development of phosphatidylinositol 3-kinase inhibitors. Curr Med
Chem. 16:2839–2854. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pang RW and Poon RT: From molecular
biology to targeted therapies for hepatocellular carcinoma: the
future is now. Oncology. 72(Suppl 1): S30–S44. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rubinsztein DC, Gestwicki JE, Murphy LO
and Klionsky DJ: Potential therapeutic applications of autophagy.
Nat Rev Drug Discov. 6:304–312. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Masuda M, Shimomura M, Kobayashi K, et al:
Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in
hepatocellular carcinoma cell lines. Oncol Rep. 26:1273–1279.
2011.PubMed/NCBI
|
|
14
|
Thomas HE, Mercer CA, Carnevalli LS, et
al: mTOR inhibitors synergize on regression, reversal of gene
expression, and autophagy in hepatocellular carcinoma. Sci Transl
Med. 4:139–184. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Herrera VA, Zeindl-Eberhart E, Jung A, et
al: The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer
cell lines. Anticancer Res. 31:849–854. 2011.PubMed/NCBI
|
|
16
|
Shire AM and Roberts LR: Prevention of
hepatocellular carcinoma: progress and challenges. Minerva
Gastroenterol Dietol. 58:49–64. 2012.PubMed/NCBI
|
|
17
|
Sandhu DS, Tharayil VS, Lai JP and Roberts
LR: Treatment options for hepatocellular carcinoma. Expert Rev
Gastroenterol Hepatol. 2:81–92. 2008. View Article : Google Scholar
|
|
18
|
Roberts LR and Gores GJ: Emerging drugs
for hepatocellular carcinoma. Expert Opin Emerg Drugs. 11:469–487.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tokunaga E, Oki E, Egashira A, et al:
Deregulation of the Akt pathway in human cancer. Curr Cancer Drug
Targets. 8:27–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou CY, Smith KD, Zhu QS, et al: Dual
targeting of AKT and mammalian target of rapamycin: a potential
therapeutic approach for malignant peripheral nerve sheath tumor.
Mol Cancer Ther. 8:1157–1168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu CX, Zhao L, Yue P, et al: Augmentation
of NVP-BEZ235’s anticancer activity against human lung cancer cells
by blockage of autophagy. Cancer Biol Ther. 12:549–555. 2011.
|
|
22
|
Mirzoeva OK, Hann B, Hom YK, et al:
Autophagy suppression promotes apoptotic cell death in response to
inhibition of the PI3K-mTOR pathway in pancreatic adenocarcinoma. J
Mol Med. 89:877–889. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jung CH, Jun CB, Ro SH, et al:
ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy
machinery. Mol Biol Cell. 20:1992–2003. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fujiwara K, Iwado E, Mills GB, et al: Akt
inhibitor shows anticancer and radiosensitizing effects in
malignant glioma cells by inducing autophagy. Int J Oncol.
31:753–760. 2007.PubMed/NCBI
|
|
25
|
Yang S, Xiao X, Meng X and Leslie KK: A
mechanism for synergy with combined mTOR and PI3 kinase inhibitors.
PLoS One. 6:e263432011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Levine B and Klionsky DJ: Development by
self-digestion: molecular mechanisms and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mizushima N and Klionsky DJ: Protein
turnover via autophagy: implications for metabolism. Annu Rev Nutr.
27:19–40. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eisenberg-Lerner A, Bialik S, Simon HU and
Kimchi A: Life and death partners: apoptosis, autophagy and the
cross-talk between them. Cell Death Differ. 16:966–975. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Y, Xing D, Zhou F and Chen Q:
Mitochondrial autophagy protects against heat shock-induced
apoptosis through reducing cytosolic cytochrome c release and
downstream caspase-3 activation. Biochem Biophys Res Commun.
395:190–195. 2010. View Article : Google Scholar
|
|
31
|
Zhuang W, Qin Z and Liang Z: The role of
autophagy in sensitizing malignant glioma cells to radiation
therapy. Acta Biochim Biophys Sin. 41:341–351. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dikic I, Johansen T and Kirkin V:
Selective autophagy in cancer development and therapy. Cancer Res.
70:3431–3434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nguyen TM, Subramanian IV, Xiao X, et al:
Endostatin induces autophagy in endothelial cells by modulating
Beclin 1 and beta-catenin levels. J Cell Mol Med. 13:3687–3698.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nguyen TM, Subramanian IV, Kelekar A and
Ramakrishnan S: Kringle 5 of human plasminogen, an angiogenesis
inhibitor, induces both autophagy and apoptotic death in
endothelial cells. Blood. 109:4793–4802. 2007. View Article : Google Scholar : PubMed/NCBI
|
